The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy-Reference-Cited by-同舟云学术

The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy

Published:2020-08-11 Issue:3 Volume:236 Page:1616-1627
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Lai Yongchang¹^ORCID,Tang Fucai¹,Huang Yapeng²,He Chengwu¹,Chen Chiheng¹,Zhao Jiquan¹,Wu Wenqi²,He Zhaohui¹^ORCID

Affiliation:

1. Department of Urology, The Eighth Affiliated Hospital Sun Yat‐Sen University Shenzhen Guangdong China

2. Guangdong Key Laboratory of Urology, Department of Urology, Minimally Invasive Surgery Center, Guangzhou Urology Research Institute The First Affiliated Hospital of Guangzhou Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29969

Reference110 articles.

1. Leptin receptor gene (A/G) polymorphism rs1137101 and renal cell carcinoma

2. Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation

3. Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

4. CCL 2 as a potential therapeutic target for clear cell renal cell carcinoma

5. VHL and HIF signalling in renal cell carcinogenesis

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma;BMC Nephrology;2024-09-10

2. T-Cell Exhaustion-Related Gene Signatures Predict Clinical Outcomes and Immunotherapy Response in Kidney Renal Clear Cell Carcinoma;2024-09-08

3. Crosstalk between GBP2 and M2 macrophage promotes the ccRCC progression;Cancer Science;2024-09-02

4. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

5. CXCL3/TGF-β-mediated crosstalk between CAFs and tumor cells augments RCC progression and sunitinib resistance;iScience;2024-07